| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/17/2008 | EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1408940B1 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions |
| 09/17/2008 | EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1284999B1 Repair of nerve damage |
| 09/17/2008 | EP1233670B1 Nitric oxide donors for inducing neurogenesis |
| 09/17/2008 | CN101268077A Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 09/17/2008 | CN101268071A Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 09/17/2008 | CN101268068A Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 09/17/2008 | CN101268067A Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as V1A receptor antagonists |
| 09/17/2008 | CN101268062A 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the GABA-B-receptor |
| 09/17/2008 | CN101268053A Alkylnitrile quinolines, as NK-3 receptor ligands |
| 09/17/2008 | CN101268052A N-oxo-heterocycle and N-oxo-alkyl quinoline-4-carboxamides as NK-3 receptor ligands |
| 09/17/2008 | CN101267822A Use of inhibitors of the Na+/H+ exchanger, subtype 5(NHE5), to improve memory retention |
| 09/17/2008 | CN101267820A Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/17/2008 | CN101267819A Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use thereof |
| 09/17/2008 | CN101267814A Association of beta3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition and therapeutic use thereof |
| 09/17/2008 | CN101265297A Alpha-synapse nucleoprotein and Sph1 interactive condition site and application thereof in screening Parkinson's disease medicament |
| 09/17/2008 | CN101265201A Method for synthesizing tramadol hydrochloride |
| 09/17/2008 | CN101265199A Method for the preparation of escitalopram |
| 09/17/2008 | CN101264326A Alzheimer's disease treatment method |
| 09/17/2008 | CN101264315A Chinese medicinal composition for treating dizziness |
| 09/17/2008 | CN101264312A Medicaments for treating dizziness |
| 09/17/2008 | CN101264304A Chinese medicine capsule for treating intractable aypnia |
| 09/17/2008 | CN101264277A Compound essential oil for controlling smoke and giving up smoking |
| 09/17/2008 | CN101264256A Chinese medicine capsule for treating intractable pain |
| 09/17/2008 | CN101264254A Medicaments for silkworm excrement vein relaxing pillow and pillow made of the same and manufacturing method of the pillow |
| 09/17/2008 | CN101264245A Chinese medicine preparations for treating headache and preparation thereof |
| 09/17/2008 | CN101264237A Medicaments assembly for recuperating sub-health and preparation thereof |
| 09/17/2008 | CN101264234A Orally-administered medicament for treating deficiency of qi and blood type dizziness |
| 09/17/2008 | CN101264230A Chinese medicinal composition for treating optic atrophy and preparation thereof |
| 09/17/2008 | CN101264209A Pure Chinese medicine with spleen-invigorating and sedative action and preparation thereof |
| 09/17/2008 | CN101264198A Jinguhuo spraying agent and preparation thereof |
| 09/17/2008 | CN101264197A Medicine for treating sciatica |
| 09/17/2008 | CN101264186A Forming method of Chinese medicine formula for preventing and controlling dizziness and its preparation |
| 09/17/2008 | CN101264172A Preparation of Chinese medicine composition for drug detoxification and application thereof |
| 09/17/2008 | CN101264171A Chinese medicine composition for drug detoxification and preparation and application thereof |
| 09/17/2008 | CN101264163A Chinese medicine powder for treating headache |
| 09/17/2008 | CN101264161A Qi-benefitting nourishing blood-nourishing sedatives and preparation thereof |
| 09/17/2008 | CN101264151A Chinese medicine for treating tension headache |
| 09/17/2008 | CN101264140A Medicinal composition for preventing birth defect and improving memory and intelligence |
| 09/17/2008 | CN101264104A Calf serum de-protein injection and producing method thereof |
| 09/17/2008 | CN101264101A Medicinal composition for preventing birth defect and improving memory in prepotency |
| 09/17/2008 | CN101264097A Use of spongosine for the treatment of pain |
| 09/17/2008 | CN101264090A Toothache-treating medicine |
| 09/17/2008 | CN101264084A Treatment of psychiatric patient with reduced hepatic function using paliperidone |
| 09/17/2008 | CN101264076A Antifatigue agent |
| 09/17/2008 | CN101264063A Stable tetrodotoxin preparations under room temperature for injection |
| 09/17/2008 | CN101264058A Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof |
| 09/17/2008 | CN101264051A Modified release pharmaceutical formulation |
| 09/17/2008 | CN101263849A Three-flower detoxifying nicotine tea |
| 09/17/2008 | CN101263848A Soboring-up liver-protecting tea |
| 09/17/2008 | CN100418968C Pirazino(aza)indole derivatives |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418954C 3h-quinazolin-4-one derivatives |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418948C Hydroxypyridine cgrp receptor antagonists |
| 09/17/2008 | CN100418550C Heart-nourishing tranquilizing Chinese medicine and its preparing method |
| 09/17/2008 | CN100418540C Medicine composition, plaster and soft paste with analgesic function |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/17/2008 | CN100418525C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 09/17/2008 | CN100418517C Alpha-aminoamide derivatives useful as antimigraine agents |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425574 Benzofuran oxyethylamines as antidepressants and anxiolytics |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425559 Medicine containing pyrimidine derivative |
| 09/16/2008 | US7425556 Compounds and uses thereof |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2447519C Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2376193C Therapeutic agent comprising a botulinum neurotoxin |
| 09/16/2008 | CA2295483C Aliphatic propargylamines as cellular rescue agents |
| 09/16/2008 | CA2123211C A method for assaying and treating alzheimer's disease |
| 09/12/2008 | WO2008109856A2 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 09/12/2008 | WO2008109810A1 Use of glucosamine as a mental and physical stress recovery enhanced and performance enhancer |
| 09/12/2008 | WO2008109724A2 Treatment of cocaine-induced fetal brain injury |
| 09/12/2008 | WO2008109610A1 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 09/12/2008 | WO2008109437A2 Compositions comprising derivatives of 3 -phenylpyridazine for treating seizure-related disorders |
| 09/12/2008 | WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | WO2008109333A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | WO2008109287A1 Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 09/12/2008 | WO2008109286A1 Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| 09/12/2008 | WO2008109285A1 Methods for treating cognitive disorders |
| 09/12/2008 | WO2008108957A2 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain |
| 09/12/2008 | WO2008108639A1 Co-crystalline forms of carbamazepine |
| 09/12/2008 | WO2008108424A1 Device for the transdermal administration of bisoprolol |